Literature DB >> 21433009

Somatoform and psychoform dissociation among students.

Benedetto Farina1, Eva Mazzotti, Paolo Pasquini, Ellert Nijenhuis, Massimo Di Giannantonio.   

Abstract

Recent evidence suggests a relationship between psychoform and somatoform dissociation both in clinical and non clinical samples. The aim of the study was to investigate the association between the two forms of dissociation among 947 university students who completed two self-administered questionnaires, the Somatoform Dissociation Questionnaire (SDQ-20) and the Dissociative Experience Scale (DES). The main result of the study was that the association between somatoform and psychoform dissociation was strong for individuals with moderate level of DES scores (O.R.=7.0), but much stronger for individuals with high level of DES scores (O.R.=18.9).
© 2011 Wiley Periodicals, Inc.

Entities:  

Mesh:

Year:  2011        PMID: 21433009     DOI: 10.1002/jclp.20787

Source DB:  PubMed          Journal:  J Clin Psychol        ISSN: 0021-9762


  5 in total

1.  Cortical thickness alterations linked to somatoform and psychological dissociation in functional neurological disorders.

Authors:  David L Perez; Nassim Matin; Benjamin Williams; Kaloyan Tanev; Nikos Makris; W Curt LaFrance; Bradford C Dickerson
Journal:  Hum Brain Mapp       Date:  2017-10-28       Impact factor: 5.038

2.  The Classification of Hysteria and Related Disorders: Historical and Phenomenological Considerations.

Authors:  Carol S North
Journal:  Behav Sci (Basel)       Date:  2015-11-06

3.  Characteristics and outcomes of children with dissociative (conversion) disorders in western China: a retrospective study.

Authors:  Zhixu Fang; Yuhang Li; Lingling Xie; Min Cheng; Jiannan Ma; Tingsong Li; Xiujuan Li; Li Jiang
Journal:  BMC Psychiatry       Date:  2021-01-12       Impact factor: 3.630

4.  'Pseudoneurological' symptoms, dissociation and stress-related psychopathology in healthy young adults.

Authors:  Petr Bob; Petra Selesova; Jiri Raboch; Lubomir Kukla
Journal:  BMC Psychiatry       Date:  2013-05-25       Impact factor: 3.630

5.  Cognitive behavioral therapy in pharmacoresistant obsessive-compulsive disorder.

Authors:  Jana Vyskocilova; Jan Prasko; Jiri Sipek
Journal:  Neuropsychiatr Dis Treat       Date:  2016-03-14       Impact factor: 2.570

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.